Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fetscher

Showing results (71-80 of 102) with videos related to

Pageof 11
Sort By:
Naunyn-Schmiedeberg'S Archives of Pharmacology|February 1, 1996
Effects of noradrenaline and neuropeptide Y on rat mesenteric microvessel contractionH Chen, C Fetscher, R F Schäfers, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|February 24, 2001
Modulation of noradrenaline-induced microvascular constriction by protein kinase inhibitorsC Fetscher, H Chen, R F Schäfers, et al.
Journal of Microbiological Methods|December 9, 2010
The application of amplicon length heterogeneity PCR (LH-PCR) for monitoring the dynamics of soil microbial communities associated with cadaver decompositionLilliana I Moreno, DeEtta Mills, Jill Fetscher, et al.
British Journal of Pharmacology|August 22, 2000
Sphingosine-1-phosphate and sphingosylphosphorylcholine constrict renal and mesenteric microvessels in vitroA Bischoff, P Czyborra, C Fetscher, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 23, 1999
Standard- and high-dose etoposide, ifosfamide, carboplatin, and epirubicin in 100 patients with small-cell lung cancer: a mature follow-up reportS Fetscher, W Brugger, R Engelhardt, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 23, 1999
Standard- and high-dose etoposide, ifosfamide, carboplatin, and epirubicin in 107 patients with non-small-cell lung cancer: a mature follow-up reportS Fetscher, W Brugger, R Engelhardt, et al.
Seminars in Oncology|April 16, 1998
Multimodality treatment including early high-dose chemotherapy with peripheral blood stem cell transplantation in limited-disease small cell lung cancerW Brugger, S Fetscher, J Hasse, et al.
Archives of Oral Biology|April 8, 2026
Lipoteichoic acid induces IL-6 production in human pulp stromal cells through TLR2-mediated NF-κB nuclear translocationTobias Akamp, Melanie Linnebank, Lea Schreiber, et al.
Oral Oncology|July 15, 2014
Poly (ADP-ribose) polymerase inhibitor efficacy in head and neck cancerJana Heitmann, Paul Geeleher, Zhixiang Zuo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1997
Dose-intense therapy with etoposide, ifosfamide, cisplatin, and epirubicin (VIP-E) in 107 consecutive patients with limited- and extensive-stage non-small-cell lung cancerS Fetscher, W Brugger, R Engelhardt, et al.
Pageof 11

Showing results (71-80 of 102) with videos related to

Sort By:
Pageof 11
Naunyn-Schmiedeberg'S Archives of Pharmacology|February 1, 1996
Effects of noradrenaline and neuropeptide Y on rat mesenteric microvessel contractionH Chen, C Fetscher, R F Schäfers, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|February 24, 2001
Modulation of noradrenaline-induced microvascular constriction by protein kinase inhibitorsC Fetscher, H Chen, R F Schäfers, et al.
Journal of Microbiological Methods|December 9, 2010
The application of amplicon length heterogeneity PCR (LH-PCR) for monitoring the dynamics of soil microbial communities associated with cadaver decompositionLilliana I Moreno, DeEtta Mills, Jill Fetscher, et al.
British Journal of Pharmacology|August 22, 2000
Sphingosine-1-phosphate and sphingosylphosphorylcholine constrict renal and mesenteric microvessels in vitroA Bischoff, P Czyborra, C Fetscher, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 23, 1999
Standard- and high-dose etoposide, ifosfamide, carboplatin, and epirubicin in 100 patients with small-cell lung cancer: a mature follow-up reportS Fetscher, W Brugger, R Engelhardt, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 23, 1999
Standard- and high-dose etoposide, ifosfamide, carboplatin, and epirubicin in 107 patients with non-small-cell lung cancer: a mature follow-up reportS Fetscher, W Brugger, R Engelhardt, et al.
Seminars in Oncology|April 16, 1998
Multimodality treatment including early high-dose chemotherapy with peripheral blood stem cell transplantation in limited-disease small cell lung cancerW Brugger, S Fetscher, J Hasse, et al.
Archives of Oral Biology|April 8, 2026
Lipoteichoic acid induces IL-6 production in human pulp stromal cells through TLR2-mediated NF-κB nuclear translocationTobias Akamp, Melanie Linnebank, Lea Schreiber, et al.
Oral Oncology|July 15, 2014
Poly (ADP-ribose) polymerase inhibitor efficacy in head and neck cancerJana Heitmann, Paul Geeleher, Zhixiang Zuo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1997
Dose-intense therapy with etoposide, ifosfamide, cisplatin, and epirubicin (VIP-E) in 107 consecutive patients with limited- and extensive-stage non-small-cell lung cancerS Fetscher, W Brugger, R Engelhardt, et al.
Pageof 11